1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an

Jette L Riis1, Claus Johansen, Borbala Gesser

  • 1Department of Dermatology, Aarhus Sygehus, Aarhus University Hospital, P.P. Orumsgade 11, 8000 Aarhus C, Denmark.

Insights

Vitamin D analog 1alpha,25(OH)(2)D(3) selectively inhibits NF-kappaB activation in human keratinocytes. This vitamin D effect is mediated by increased IkappaBalpha, reducing IL-8 gene transcription.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • Nuclear factor kappa B (NF-kappaB) is a transcription factor regulating genes like IL-8 and p53.
  • In resting cells, NF-kappaB is sequestered in the cytoplasm by inhibitory kappaB (IkappaB) proteins.

Purpose of the Study:

  • To investigate the impact of 1alpha,25(OH)(2)D(3) on NF-kappaB activation in normal human keratinocytes.
  • To determine the effect of 1alpha,25(OH)(2)D(3) on NF-kappaB binding to IL-8 and p53 promoter sequences.

Main Methods:

  • Electrophoretic Mobility Shift Assay (EMSA) to assess NF-kappaB DNA binding activity.
  • Western blotting to measure IkappaBalpha and p53 expression.
  • Enzyme-Linked Immunosorbent Assay (ELISA) to quantify IL-8 expression.

Main Results:

  • IL-1alpha stimulation significantly increased NF-kappaB binding to both IL-8 and p53 promoter sequences.
  • 1alpha,25(OH)(2)D(3) treatment significantly upregulated IkappaBalpha expression.
  • 1alpha,25(OH)(2)D(3) markedly reduced IL-1alpha-induced NF-kappaB binding to the IL-8 promoter and IL-8 expression, with a lesser effect on the p53 promoter.

Conclusions:

  • 1alpha,25(OH)(2)D(3) selectively inhibits NF-kappaB binding to the IL-8 promoter over the p53 promoter in keratinocytes.
  • Increased IkappaBalpha expression induced by 1alpha,25(OH)(2)D(3) likely mediates this selective inhibition.
  • This suggests a role for 1alpha,25(OH)(2)D(3) in regulating specific NF-kappaB-dependent gene transcription pathways.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...